drugset

drugset / Trial / NCT00751127

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT00751127 ↗

Phase 3 Completed 268 enrolled Pfizer

RandomizedParallel-groupTriple-blindTreatment

Summary

PhXA41 is not inferior to timolol

Timeline

Start: 1993-01
Primary completion: 1994-02
Completion: 1994-02

Publications

Varma R, Hwang LJ, Grunden JW, Bean GW, Sultan MB. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range. Am J Ophthalmol. 2009 Aug;148(2):221-6. doi: 10.1016/j.ajo.2009.02.035. Epub 2009 May 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Latanoprost	Small molecule	—	Other
Comparator	Timolol	Other / unclassified	—	Other

Indications